Share

Press conferences on the occasion of the 22nd ECNP Congress

Sept. 12-16, 2009, Istanbul, Turkey

Mental disorders are a global problem and, in view of some 500 million people affected worldwide, represent one of the biggest challenges for health care systems. At the 22nd ECNP Congress in Istanbul, more than 600 renowned experts from 25 countries will present the latest achievements in neuropsychopharmacology covering virtually all disorders of the brain and give an outlook on novel treatments for mental disorders.

We would like to draw your attention to the three press conferences during the 22nd ECNP Congress, which will deal with the crucial role of genetic factors in aggressive and antisocial behaviour as well as in attention deficit/hyperactivity disorder (ADHD) in adults. Furthermore, Professor Carpenter, USA, will present the current paradigm shift in schizophrenia research, which will raise the possibility of very early intervention and secondary prevention in schizophrenia.

Please find below the topics of the press conferences. All press conferences will be held from 10.00-10.45 hours in Room Galata, level 0 of the congress main building:

Sunday, 13 September 2009
Are the monoamines involved in shaping conduct disorders?
Speaker: Professor Lars Oreland, M.D., Ph.D., Sweden
Moderator: Professor Celso Arango, M.D., Spain

Monday, 14 September 2009
The future of schizophrenia
Speaker: Professor William T. Carpenter Jr., M.D., USA
Moderator: Professor René S. Kahn, M.D., The Netherlands

Tuesday, 15 September 2009
The role of genetic factors in adult ADHD
Speaker: Assoc. Prof. Barbara Franke, Ph.D., The Netherlands
Moderator: Professor Hans-Ulrich Wittchen, M.D., Ph.D., Germany

Share

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.